DE2239633A1 - Verwendung von anhydridfreier acetylsalicylsaeure - Google Patents
Verwendung von anhydridfreier acetylsalicylsaeureInfo
- Publication number
- DE2239633A1 DE2239633A1 DE2239633A DE2239633A DE2239633A1 DE 2239633 A1 DE2239633 A1 DE 2239633A1 DE 2239633 A DE2239633 A DE 2239633A DE 2239633 A DE2239633 A DE 2239633A DE 2239633 A1 DE2239633 A1 DE 2239633A1
- Authority
- DE
- Germany
- Prior art keywords
- anhydride
- asan
- salicylic acid
- free
- asa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title claims description 17
- 229960001138 acetylsalicylic acid Drugs 0.000 title claims description 7
- 239000003814 drug Substances 0.000 claims description 3
- 230000000202 analgesic effect Effects 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 208000021769 Acute sensory ataxic neuropathy Diseases 0.000 description 18
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 description 4
- 239000011736 potassium bicarbonate Substances 0.000 description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000009183 running Effects 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- OAWXYINGQXLWOE-UHFFFAOYSA-N (2-acetyloxybenzoyl) 2-acetyloxybenzoate Chemical compound CC(=O)OC1=CC=CC=C1C(=O)OC(=O)C1=CC=CC=C1OC(C)=O OAWXYINGQXLWOE-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XGGLLRJQCZROSE-UHFFFAOYSA-K ammonium iron(iii) sulfate Chemical compound [NH4+].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O XGGLLRJQCZROSE-UHFFFAOYSA-K 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- BZOWUXJHDBYBRL-UHFFFAOYSA-N butan-2-one;cyclohexane Chemical compound CCC(C)=O.C1CCCCC1 BZOWUXJHDBYBRL-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2239633A DE2239633A1 (de) | 1972-08-11 | 1972-08-11 | Verwendung von anhydridfreier acetylsalicylsaeure |
| DD172321A DD104504A6 (enExample) | 1972-08-11 | 1973-07-17 | |
| FR7329405A FR2195451A2 (en) | 1972-08-11 | 1973-08-10 | Pure acetyl salicyclic acid - for prodn of medicaments free from immunoglobulin-gical side-effects |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2239633A DE2239633A1 (de) | 1972-08-11 | 1972-08-11 | Verwendung von anhydridfreier acetylsalicylsaeure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2239633A1 true DE2239633A1 (de) | 1974-02-28 |
Family
ID=5853375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2239633A Pending DE2239633A1 (de) | 1972-08-11 | 1972-08-11 | Verwendung von anhydridfreier acetylsalicylsaeure |
Country Status (3)
| Country | Link |
|---|---|
| DD (1) | DD104504A6 (enExample) |
| DE (1) | DE2239633A1 (enExample) |
| FR (1) | FR2195451A2 (enExample) |
-
1972
- 1972-08-11 DE DE2239633A patent/DE2239633A1/de active Pending
-
1973
- 1973-07-17 DD DD172321A patent/DD104504A6/xx unknown
- 1973-08-10 FR FR7329405A patent/FR2195451A2/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2195451A2 (en) | 1974-03-08 |
| DD104504A6 (enExample) | 1974-03-12 |
| FR2195451B2 (enExample) | 1977-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2825216A1 (de) | Vorrichtung zum erzeugen von technetium-99m | |
| EP0402347B1 (de) | Verfahren zur Abtrennung von Aminen | |
| DE2630757C2 (de) | L-Pyroglutamyl-L-prolinamid, Verfahren zur Herstellung und diese Verbindung enthaltende Arzneimittel | |
| DE2239633A1 (de) | Verwendung von anhydridfreier acetylsalicylsaeure | |
| DE925064C (de) | Verfahren zur Trennung der Komponenten des Actinomycins C | |
| DE718034C (de) | Verfahren zur Anreicherung von Lactoflavin | |
| DE1939695C3 (de) | Gewinnung von d-Xylose aus Sulfitlauge von Hartholz mit Hilfe von azeotropischem Isopropylalkohol | |
| DE3788698T2 (de) | Verfahren zur Herstellung von Salzen der Mercaptoäthylsulfonsäure. | |
| DE2515084A1 (de) | Verfahren zur herstellung von mono- o-beta-hydroxyaethyl-7 rutin | |
| DE951162C (de) | Reinigung und Trennung von Vitaminen der B-Gruppe durch Adsorptionschromatographie | |
| DE2227813A1 (de) | Verfahren zur herstellung eines substituierten pyrazolidinderivats | |
| AT162055B (de) | Verfahren zur Herstellung von therapeutisch wirksamen Präparaten aus Primula und Thymian und/oder Quendel. | |
| DE665511C (de) | Verfahren zur Darstellung des wirksamen Bestandteils des Calebassen-Curare in kristallisierter, reiner Form | |
| DE2230794C3 (de) | Verfahren zur Trennung von Orthophosphorsäuremono- und di'estern | |
| AT253506B (de) | Verfahren zur extraktiven Gewinnung der neuen α-Amino-3-hydroxy-5-isoxazolessigsäure | |
| DE892228C (de) | Verfahren zur chromatographischen Reinigung und Fraktionierung von corticoide Hormone enthaltenden Extrakten | |
| DE1417605A1 (de) | Verfahren zur Reinigung von Gibberellinen | |
| AT155064B (de) | Verfahren zur Gewinnung oder Reinigung von therapeutisch wirksamen Präparaten. | |
| DE2139310C3 (de) | Verfahren zur Herstellung von L-Pyroglutamyl-L-histidyl-L-prolinamid | |
| DE809461C (de) | Verfahren zur Herstellung eines Penicillinsalzes mit protrahierter Wirkung | |
| DE2521905A1 (de) | Fumarsaeuresalz des 1-diaethylamino- aethyl-3-(p-methoxybenzyl)-1,2-dihydro- chinoxalin-2-ons, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel | |
| DE953643C (de) | Verfahren zur Abtrennung und Gewinnung von Vitamin B aus einem Verunreinigungen enthaltenden Vitamin-B-aktiven Konzentrat | |
| DE499950C (de) | Verfahren zur Darstellung therapeutisch wertvoller Derivate des Cholins | |
| DE2522224A1 (de) | Jodierte verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE3319756A1 (de) | Verfahren zur abtrennung von karminsaeure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHW | Rejection |